SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYPB - Cypress BioScience
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jay Lowe who wrote (267)6/3/1998 12:22:00 AM
From: Jay Lowe  Read Replies (1) of 586
 
I suspect a connection between the reverse merger business
and the private investor holdings.

I suspect a shift of money from privates to the funds is
being engineered to lock in profits for the privates, i.e.,
open CYPB to the funds and retail brokerages would create
demand which the large private could fulfill. This may be
a commonsense hedge move driven by the votes of the privates.

I, for one, would welcome such a transition if the company
remains on track.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News